Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
23.68
-1.00 (-4.05%)
At close: May 22, 2026, 4:00 PM EDT
23.77
+0.09 (0.36%)
After-hours: May 22, 2026, 6:57 PM EDT

10x Genomics Revenue

10x Genomics had revenue of $150.84M in the quarter ending March 31, 2026, a decrease of -2.61%. This brings the company's revenue in the last twelve months to $638.78M, up 2.26% year-over-year. In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth.

Revenue (ttm)
$638.78M
Revenue Growth
+2.26%
P/S Ratio
4.71
Revenue / Employee
$542,261
Employees
1,178
Market Cap
3.01B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025642.82M32.04M5.25%
Dec 31, 2024610.79M-7.94M-1.28%
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Teladoc Health2.51B
Privia Health Group2.25B
Tempus AI1.36B
HealthEquity1.31B
Omnicell1.23B
Waystar Holding1.16B
Hinge Health646.34M
Doximity644.86M
Revenue Rankings

TXG News

More News